Profit

BSE Code: | NSE Code: | ISIN: | Sector:

NSE
778.50
Change Change %
-2.10 -0.27%

Updated:16 Nov, 2018, 14:24 PM IST

BSE
776.00
Change Change %
-4.20 -0.54%

Updated:16 Nov, 2018, 14:52 PM IST

Research Report Detail

Brokerage
Analyst
Report Date Call Price@Call Target Price
Stop Loss
Current Status Time Horizon
CLSA
N/A
01-04-2016 Sell 725.00 630.00
N/A
Target Hit Long (1Y)
01-04-2017

CLSA maintains sell on Aurobindo Pharma

CLSA has maintained sell on Aurobindo Pharma for target price of Rs 630. CLSA says Aurobindo should trade at discount to peers and see several challenges & muted growth. It adds that EBITDA margin is unlikely to improve and balance sheet is weaker than peers. CLSA expects slow earnings growth phase and valuations are cheap only optically.

Top